Autobio Diagnostics Co (SHSE:603658) Piotroski F-Score: 6 (As of Aug. 27, 2026) — 20% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603658 Autobio Diagnostics Co Ltd SHSE:603658
95 GF Score
Price ¥32.67
GF Value ¥40.43
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Autobio Diagnostics Co Piotroski F-Score?

Autobio Diagnostics Co SHSE:603658 -2.21% 95 Piotroski F-Score is 6 as of Aug. 27, 2026, which is 20% above its 10-year median of 5.00. GuruFocus rates SHSE:603658 with a GF Score™ of 95/100 and a GF Value™ of ¥40.43 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Autobio Diagnostics Co ranks better than 80.12% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Autobio Diagnostics Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Autobio Diagnostics Co's Piotroski F-Score or its related term are showing as below:

SHSE:603658' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 8
Current: 6

During the past 13 years, the highest Piotroski F-Score of Autobio Diagnostics Co was 8. The lowest was 3. And the median was 5.

Autobio Diagnostics Co  (SHSE:603658) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Autobio Diagnostics Co Piotroski F-Score Related Terms


Autobio Diagnostics Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Autobio Diagnostics Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Autobio Diagnostics Co Piotroski F-Score Chart

Autobio Diagnostics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 8.00 5.00 6.00 6.00

Autobio Diagnostics Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 6.00 6.00 6.00 6.00

SHSE:603658 vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Autobio Diagnostics Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Autobio Diagnostics Co Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's Piotroski F-Score falls into.


SHSE:603658
95GF Score
Autobio Diagnostics Co Ltd SHSE:603658
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was 288.514 + 208.501 + 236.447 + 260.677 = ¥994 Mil.
Cash Flow from Operations was 435.238 + 496.26 + 146.573 + 69.269 = ¥1,147 Mil.
Revenue was 1066.849 + 1099.257 + 992.202 + 1065.725 = ¥4,224 Mil.
Gross Profit was 699.929 + 746.711 + 661.209 + 722.685 = ¥2,831 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(11645.384 + 11726.945 + 12289.725 + 12242.218 + 11784.102) / 5 = ¥11937.6748 Mil.
Total Assets at the begining of this year (Jun25) was ¥11,645 Mil.
Long-Term Debt & Capital Lease Obligation was ¥8 Mil.
Total Current Assets was ¥5,513 Mil.
Total Current Liabilities was ¥2,273 Mil.
Net Income was 336.661 + 238.277 + 269.88 + 301.121 = ¥1,146 Mil.

Revenue was 1172.931 + 1091.167 + 995.934 + 1064.374 = ¥4,324 Mil.
Gross Profit was 780.832 + 704.969 + 648.08 + 679.393 = ¥2,813 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(11037.703 + 11389.47 + 11875.066 + 11968.032 + 11645.384) / 5 = ¥11583.131 Mil.
Total Assets at the begining of last year (Jun24) was ¥11,038 Mil.
Long-Term Debt & Capital Lease Obligation was ¥18 Mil.
Total Current Assets was ¥5,931 Mil.
Total Current Liabilities was ¥2,532 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Autobio Diagnostics Co's current Net Income (TTM) was 994. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Autobio Diagnostics Co's current Cash Flow from Operations (TTM) was 1,147. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=994.139/11645.384
=0.08536764

ROA (Last Year)=Net Income/Total Assets (Jun24)
=1145.939/11037.703
=0.10382042

Autobio Diagnostics Co's return on assets of this year was 0.08536764. Autobio Diagnostics Co's return on assets of last year was 0.10382042. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Autobio Diagnostics Co's current Net Income (TTM) was 994. Autobio Diagnostics Co's current Cash Flow from Operations (TTM) was 1,147. ==> 1,147 > 994 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=8.371/11937.6748
=0.00070123

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=18.31/11583.131
=0.00158075

Autobio Diagnostics Co's gearing of this year was 0.00070123. Autobio Diagnostics Co's gearing of last year was 0.00158075. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=5512.858/2273.382
=2.42495894

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=5930.68/2531.681
=2.34258582

Autobio Diagnostics Co's current ratio of this year was 2.42495894. Autobio Diagnostics Co's current ratio of last year was 2.34258582. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Autobio Diagnostics Co's number of shares in issue this year was 566.113. Autobio Diagnostics Co's number of shares in issue last year was 545.397. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2830.534/4224.033
=0.67010225

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=2813.274/4324.406
=0.65055733

Autobio Diagnostics Co's gross margin of this year was 0.67010225. Autobio Diagnostics Co's gross margin of last year was 0.65055733. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=4224.033/11645.384
=0.36272166

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=4324.406/11037.703
=0.39178496

Autobio Diagnostics Co's asset turnover of this year was 0.36272166. Autobio Diagnostics Co's asset turnover of last year was 0.39178496. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+0+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Autobio Diagnostics Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Autobio Diagnostics Co (SHSE:603658) has a Piotroski F-Score of 6 as of Aug. 27, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Autobio Diagnostics Co and its competitors. This is 20% above median its historical median of 5.00. Over the past decade, Autobio Diagnostics Co's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Autobio Diagnostics Co ranks #161 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 19.9%.
Is Autobio Diagnostics Co's Piotroski F-Score too high?
Autobio Diagnostics Co's current Piotroski F-Score of 6 is 20% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Autobio Diagnostics Co's value of 6 is 20% above this industry median. Based on the distribution chart, Autobio Diagnostics Co ranks #161 out of 810 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Autobio Diagnostics Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Autobio Diagnostics Co's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Autobio Diagnostics Co ranks #161 out of 810 companies for Piotroski F-Score. This places Autobio Diagnostics Co in the top 20% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Autobio Diagnostics Co's value of 6 is 20% above this benchmark. Historically, Autobio Diagnostics Co's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Autobio Diagnostics Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Autobio Diagnostics Co's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Autobio Diagnostics Co and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Autobio Diagnostics Co's current Piotroski F-Score is 6, which is 20% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Autobio Diagnostics Co stock overvalued right now?
Based on GuruFocus' analysis, Autobio Diagnostics Co (SHSE:603658) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥40.43, compared to a current price of ¥32.67 — trading 19.2% below its estimated fair value. The current Piotroski F-Score is 6, which is 20% above median its 10-year median of 5.00 and 20% above the Medical Devices & Instruments industry median of 5.00. Autobio Diagnostics Co's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Autobio Diagnostics Co (SHSE:603658), the current Piotroski F-Score is 6 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Autobio Diagnostics Co (SHSE:603658) Overvalued in 2026?

Based on GuruFocus' analysis, Autobio Diagnostics Co stock appears to be undervalued. The current stock price of ¥32.67 is trading 19.2% below its estimated GF Value™ of ¥40.43. GuruFocus considers Autobio Diagnostics Co to be Modestly Undervalued.

Key valuation signals for SHSE:603658:

  • Piotroski F-Score: 6 (20% above median its 10-year median of 5.00)
  • GF Value™: ¥40.43 vs. price of ¥32.67 (19.2% below fair value)
  • GF Score™: 95/100 with 3 warning signs
  • Industry Position: 20% above the Medical Devices & Instruments median (#161 of 810)

No single metric tells the full story. See the SHSE:603658 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Autobio Diagnostics Co Business Description

Address No. 199, Jingkai 15th Street, Economic and Technological Development Zone, Zhengzhou, CHN, 450016
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, and sales of in vitro diagnostic reagents and instruments. The company's main products include immunoassay, microbiological, molecular diagnostic, and biochemical reagents, along with immunoassay, microbiological, molecular detection, and mass spectrometry instruments, as well as auxiliary testing devices.
95GF Score

Get the complete analysis for SHSE:603658

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥32.67
Price
¥40.43
GF Value